HIV 1/2 AG-AB, RAPID

LAB3023

Rapid HIV

Reactive results will reflex to HIV confirmation send out. 

7 mL Red Top Tube 

4.0 mL

Grossly hemolyzed or contaminated samples

Set Up:DAILY Report Available:1 HOUR

Set Up: Daily;  Report Available: 1 hour

Non Reactive

Rapid Testing During Labor · Any woman with undocumented HIV status at the time of labor should be screened with a rapid HIV test unless she declines (opt-out screening). · Reasons for declining a rapid test should be explored (see "Addressing Reasons for Declining Testing," above). · Immediate initiation of appropriate antiretroviral prophylaxis should be recommended to women on the basis of a reactive rapid test result without waiting for the result of a confirmatory test (Perinatal HIV Guidelines Working Group, 2006). (Also see NGC summary of Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States.) Postpartum/Newborn Testing · When a woman's HIV status is still unknown at the time of delivery, she should be screened immediately postpartum with a rapid HIV test unless she declines (opt-out screening). · When the mother's HIV status is unknown postpartum, rapid testing of the newborn as soon as possible after birth is recommended so antiretroviral prophylaxis can be offered to HIV-exposed infants. Women should be informed that identifying HIV antibodies in the newborn indicates that the mother is infected. · For infants whose HIV exposure status is unknown and who are in foster care, the person legally authorized to provide consent should be informed that rapid HIV testing is recommended for infants whose biologic mothers have not been tested. · The benefits of neonatal antiretroviral prophylaxis are best realized when it is initiated <12 hours after birth (Wade et al., 1998). Confirmatory Testing · Whenever possible, uncertainties regarding laboratory test results indicating HIV infection status should be resolved before final decisions are made regarding reproductive options, antiretroviral therapy, cesarean delivery, or other interventions. · If the confirmatory test result is not available before delivery, immediate initiation of appropriate antiretroviral prophylaxis should be recommended to any pregnant patient whose HIV screening test result is reactive to reduce the risk for perinatal transmission (USPHS, 2006). (Also see NGC summary of Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States.) References: 1. Review of the Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings from Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE, Centers for Disease Control and Prevention (CDC). 2. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006 Sep 22;55(RR-14)